Endobronchial brachytherapy in the treatment of malignant lung tumours
| Autor: | T. Gutiérrez Jiménez, R. Sáez Valls, J I Granda-Orive, J A Escobar-Sacristán, J M Delgado, A Rodero Baños |
|---|---|
| Rok vydání: | 2004 |
| Předmět: |
Pulmonary and Respiratory Medicine
Male medicine.medical_specialty Lung Neoplasms Stridor Brachytherapy Bronchi Malignancy Bronchospasm Bronchoscopy medicine Humans Prospective Studies Prospective cohort study Pneumonitis Endobronchial brachytherapy Lung business.industry Radiotherapy Dosage Middle Aged medicine.disease Iridium Radioisotopes Bronchial Fistula Combined Modality Therapy Surgery medicine.anatomical_structure Carcinoma Squamous Cell Female Radiology medicine.symptom business |
| Zdroj: | The European respiratory journal. 24(3) |
| ISSN: | 0903-1936 |
| Popis: | A prospective study was made to assess the short-term clinical and endoscopic response to high-dose-rate endobronchial brachytherapy (HDREB) in patients with malignant endobronchial tumours. From July 1995 to May 2000, 288 HDREB sessions were carried out on 81 patients. The mean patient age was 61.57 yrs (range 34–82); males were predominant (87.65%). Tumours were primary in 76 patients (93.82%) and metastatic in five patients (6.18%). The inclusion criteria were malignant endobronchial tumour and either palliative treatment for incurable disease or intent-to-cure treatment for residual malignancy on the bronchial resection surface after surgery or an inoperable tumour. The exclusion criteria were as follows: impediments to catheter placement, expected survival |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|